Table 1.
Patient and primary tumor characteristics (n = 10)
| No. of patients | Percentage (%) | |
|---|---|---|
| Age at implant (years) | ||
| Median (range) | 15 (4–20) | |
| Gender | ||
| Male | 7 | 70 |
| Female | 3 | 30 |
| Pathology of primary tumor | ||
| Fibrosarcoma | 5 | 50 |
| Alveolar soft tissue sarcoma | 2 | 20 |
| Primitive neuroectodermal tumor | 1 | 10 |
| Epithelioid sarcoma | 1 | 10 |
| Rhabdomyosarcoma | 1 | 10 |
| Primary tumor stage (AJCC 7th de, 2010) | ||
| I A | 3 | 30 |
| II A | 1 | 10 |
| III | 3 | 30 |
| IV | 3 | 30 |
| Pre-seed implant therapy | ||
| Surgery + EBRT + CTx | 1 | 10 |
| Surgery + EBRT | 3 | 30 |
| Surgery + CTx | 1 | 10 |
| EBRT + CTx | 2 | 20 |
| Surgery | 3 | 30 |
| Follow-up (month) | ||
| Median (range) | 27.5 (6–107) |
Abbreviations: AJCC American Joint Committee on Cancer, EBRT external beam radiotherapy, CTx chemotherapy